VESIcare For Improving OAB Symptoms in Patients Undergoing IGRT of the Prostate
Status:
Terminated
Trial end date:
2014-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if Vesicare (Solifenacin succinate) is effective in
treating over-active bladder symptoms during radiation therapy of the prostate.